Guardant Health Inc. (GH)
Guardant Health Statistics
Share Statistics
Guardant Health has 123.42M shares outstanding. The number of shares has increased by 0.86% in one year.
| Shares Outstanding | 123.42M |
| Shares Change (YoY) | 0.86% |
| Shares Change (QoQ) | -0.11% |
| Owned by Institutions (%) | 97.11% |
| Shares Floating | 117.04M |
| Failed to Deliver (FTD) Shares | 63 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 8.28M, so 6.71% of the outstanding shares have been sold short.
| Short Interest | 8.28M |
| Short % of Shares Out | 6.71% |
| Short % of Float | 6.99% |
| Short Ratio (days to cover) | 4.99 |
Valuation Ratios
The PE ratio is -8.59 and the forward PE ratio is -18.15. Guardant Health's PEG ratio is 0.51.
| PE Ratio | -8.59 |
| Forward PE | -18.15 |
| PS Ratio | 5.07 |
| Forward PS | 3.4 |
| PB Ratio | -26.85 |
| P/FCF Ratio | -13.64 |
| PEG Ratio | 0.51 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Guardant Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.68, with a Debt / Equity ratio of -9.57.
| Current Ratio | 4.68 |
| Quick Ratio | 4.36 |
| Debt / Equity | -9.57 |
| Debt / EBITDA | -3.42 |
| Debt / FCF | -4.86 |
| Interest Coverage | -171.87 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $369.69K |
| Profits Per Employee | $-218.3K |
| Employee Count | 1,999 |
| Asset Turnover | 0.5 |
| Inventory Turnover | 4.08 |
Taxes
| Income Tax | 1.28M |
| Effective Tax Rate | -0.3% |
Stock Price Statistics
The stock price has increased by 169.95% in the last 52 weeks. The beta is 1.45, so Guardant Health's price volatility has been higher than the market average.
| Beta | 1.45 |
| 52-Week Price Change | 169.95% |
| 50-Day Moving Average | 43.59 |
| 200-Day Moving Average | 33.66 |
| Relative Strength Index (RSI) | 54.12 |
| Average Volume (20 Days) | 2.35M |
Income Statement
In the last 12 months, Guardant Health had revenue of 739.02M and earned -436.37M in profits. Earnings per share was -3.56.
| Revenue | 739.02M |
| Gross Profit | 449.22M |
| Operating Income | -443.59M |
| Net Income | -436.37M |
| EBITDA | -390.12M |
| EBIT | -432.51M |
| Earnings Per Share (EPS) | -3.56 |
Balance Sheet
The company has 525.54M in cash and 1.34B in debt, giving a net cash position of -810.51M.
| Cash & Cash Equivalents | 525.54M |
| Total Debt | 1.34B |
| Net Cash | -810.51M |
| Retained Earnings | -2.58B |
| Total Assets | 1.49B |
| Working Capital | 829.53M |
Cash Flow
In the last 12 months, operating cash flow was -239.86M and capital expenditures -35.09M, giving a free cash flow of -274.94M.
| Operating Cash Flow | -239.86M |
| Capital Expenditures | -35.09M |
| Free Cash Flow | -274.94M |
| FCF Per Share | -2.24 |
Margins
Gross margin is 60.79%, with operating and profit margins of -60.02% and -59.05%.
| Gross Margin | 60.79% |
| Operating Margin | -60.02% |
| Pretax Margin | -58.87% |
| Profit Margin | -59.05% |
| EBITDA Margin | -52.79% |
| EBIT Margin | -60.02% |
| FCF Margin | -37.2% |
Dividends & Yields
GH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for GH is $52, which is 15.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $52 |
| Price Target Difference | 15.6% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
Scores
| Altman Z-Score | -0.19 |
| Piotroski F-Score | 2 |